Finance and efficiency

Reckitt Benckiser fined for anti-competitive activity

By 2010-10-15T10:07:00

Household goods giant Reckitt Benckiser has been fined £10.2m for abusing its dominant position in the supply of its Gaviscon heartburn treatment to the NHS.

Source: Andres Rodriguez - Fotolia

Household goods giant Reckitt Benckiser has been fined £10.2m for abusing its dominant position in the supply of its Gaviscon heartburn treatment to the NHS.

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
  • 10 expert briefings every fortnight (Premium only)

Subscribe

to HSJ

Already a subscriber? Sign into your account here